Document is current
Any future updates will be listed below
-
Authors
Bone, Robert A
Lowndes, Molly P https://orcid.org/0000-0003-3692-7847
Raineri, Silvia https://orcid.org/0000-0003-4381-1033
R Riveiro, Alba https://orcid.org/0000-0002-7015-2486
Lundregan, Sarah L
Dall, Morten https://orcid.org/0000-0002-8577-3162
Sulek, Karolina
Romero, Jose A H https://orcid.org/0000-0002-4765-2087
Malzard, Luna
Koigi, Sandra
Heckenbach, Indra J
Solis-Mezarino, Victor
Völker-Albert, Moritz
Vasilopoulou, Catherine G
Meier, Florian https://orcid.org/0000-0003-4729-175X
Trusina, Ala https://orcid.org/0000-0003-1945-454X
Mann, Matthias https://orcid.org/0000-0003-1292-4799
L Nielsen, Michael https://orcid.org/0000-0002-0067-9039
Treebak, Jonas T https://orcid.org/0000-0003-1488-7012
Brickman, Joshua M https://orcid.org/0000-0003-1580-7491
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF21CC0073729)
Lundbeck Foundation (DFF-8020-00100B)
Lundbeck Foundation (DFF-0134-00022B)
Lundbeck Foundation (DFF-2034-00025B)
Lundbeck Foundation (R208-2015-2872)
Danmarks Grundforskningsfond (DNRF116)
Danmarks Grundforskningsfond (DNRF116)
Novo Nordisk Foundation Center for Basic Metabolic Research (NNF18CC0034900)
Novo Nordisk Foundation Center for Protein Research (NNF14CC0001)
Novo Nordisk Foundation Center for Protein Research (NNF24SA0098829)
European Union (101097979)
- License Information
-
More Information
Article History
Received: 18 December 2024
Revised: 3 February 2025
Accepted: 3 March 2025
First Online: 25 April 2025
Change Date: 2 May 2025
Change Type: Update
Change Details: The Peer Review File was corrected.
Disclosure and competing interests statement
: The authors RAB and JMB have filed a patent on the use of EMM for stem cell culture. The remaining authors declare no competing interests.
